Dr Duduzile Ndwandwe (Ph.D., Master of Advanced Studies in Vaccinology, MSc Bacterial genetics, BSc H, BSc) is a Vaccinologist at Cochrane South Africa, an intramural unit of the South African Medical Research Council (SAMRC). She is a Deputy Director of Cochrane South Africa and leads the Clinical Trials Registry portfolio (Pan African Clinical Trials Registry (PACTR) and South African National Clinical Trials Registry (SANCTR)). The clinical trial registries are housed and maintained at the SAMRC to ensure transparency of clinical research in South Africa and Africa.
Dr Ndwandwe has a PhD in Molecular Mycobacteriology received from the University of the Witwatersrand at Molecular Mycobacteriology Research Unit (MMRU), an extra-mural research Unit of the SAMRC. She also leads the vaccine implementation research portfolio of the Unit in which she conducts primary and secondary research on vaccine-related topics. Her previous work had been on implementing various HIV prevention clinical trials in South Africa and currently engages with critical stakeholders National and regionally to promote transparency of evidence generated in the conduct of clinical trials.
Dr Ndwandwe has published in peer-reviewed in high-impact factor journals. She serves on various global and national working groups for COVID-19 research networks and vaccine-related topics. Besides COVID-19 research networks, Dr Ndwandwe is involved in the GloPID-R, a global research coalition for infectious disease preparedness where she participates in the numerous groups within the GloPID-R. She is amongst the members of the SAMRC members who are setting up the GloPID-R Africa Hub.
Additionally, Dr Ndwandwe is involved in community engagement projects and knowledge sharing, where she serves as a non-executive director and board chair of Eh! Woza, a non-profit organization that seeks to advance community engagement on relevant public health issues such as COVID-19 and TB.